TY - JOUR
T1 - Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen
AU - Robertson, David W.
AU - Katzenellenbogen, John A.
AU - Long, Deborah J.
AU - Rorke, Ellen A.
AU - Katzenellenbogen, Benita S.
N1 - Funding Information:
Acknowltidgemenrs-Wae re gratefult o Dr A. Todd (ICI Ltd, Macclesfield,U .K.) and Dr L. Trench (ICI America) for supplying samples of cis-tamoxifen,t rans-tamoxifen, and t&s-hydroxytamoxifen,a nd to Dr H. Rochefort for communicatingw ith us prior to publicationT. he assistance of P. Dorsey is gratefullya cknowledgedS. upport of this researchw as providedb y grants from National Institutes of Health USPH AM 15556 Ito J.A.K.) and USPH CA18119( to B.S.K.). D.W.R. wass upportedby fellowships from the University of Illinois and the Lubrizol Corporation.
PY - 1982/1
Y1 - 1982/1
N2 - In the rat uterus, trans-tamoxifen (ICI-47,699, 1-[4-(2-dimethylaminoethoxy)phenyl]-1,2-diphenylbut-1(E)-ene) is a full estrogen agonist, while trans-tamoxifen (ICI-46,474, 1-[4-(2-dimethylaminoethoxy)phenyl]-1,2-diphenylbut-1(Z)-ene is a partial antagonist-partial agonist. In this investigation, we have compared the bioactivity of the tamoxifen isomers in the rat, and utilizing these isomers in tritium-labeled form, we have examined their metabolism and pharmacodynamics. In immature rats, trans-tamoxifen is a partial agonist-partial antagonist in terms of uterine weight stimulation, while cis-tamoxifen is a pure agonist; both isomers give little stimulation of uterine peroxidase, while only trans-tamoxifen is able to antagonize peroxidase stimulation by estradiol. After administration of [3H]-trans-tamoxifen to rats in vivo, there is a progressive accumulation of trans-hydroxytamoxifen and a yet more polar metabolite in the nuclear fraction of the uterus. With [3Hcis-tamoxifen, on the other hand, there is no accumulation of these metabolites in the uterus: in the nuclear fraction, there is a metabolite that is slightly less polar than cis-hydroxytamoxifen, and in the cytosol, a metabolite slightly more polar than cis-tamoxifen (but different from the nuclear metabolite). There is no evidence for isomerization of the isomers of tamoxifen or hydroxytamoxifen. In in vitro incubations with rat liver microsomes, both [3H]-trans-tamoxifen and [3H]-cis-tamoxifen undergo hydroxylation and to a lesser extent demethylation. Thus, the selective accumulation of trans-hydroxytamoxifen in the uterus appears to result from its greater affinity tor the estrogen receptor (285%, vs estradiol = 100%) relative to that of cis-hydroxytamoxifen (5%). The different metabolites that accumulate in the uterus following treatment with trans or cis tamoxifen may account for their different agonist-antagonist character.
AB - In the rat uterus, trans-tamoxifen (ICI-47,699, 1-[4-(2-dimethylaminoethoxy)phenyl]-1,2-diphenylbut-1(E)-ene) is a full estrogen agonist, while trans-tamoxifen (ICI-46,474, 1-[4-(2-dimethylaminoethoxy)phenyl]-1,2-diphenylbut-1(Z)-ene is a partial antagonist-partial agonist. In this investigation, we have compared the bioactivity of the tamoxifen isomers in the rat, and utilizing these isomers in tritium-labeled form, we have examined their metabolism and pharmacodynamics. In immature rats, trans-tamoxifen is a partial agonist-partial antagonist in terms of uterine weight stimulation, while cis-tamoxifen is a pure agonist; both isomers give little stimulation of uterine peroxidase, while only trans-tamoxifen is able to antagonize peroxidase stimulation by estradiol. After administration of [3H]-trans-tamoxifen to rats in vivo, there is a progressive accumulation of trans-hydroxytamoxifen and a yet more polar metabolite in the nuclear fraction of the uterus. With [3Hcis-tamoxifen, on the other hand, there is no accumulation of these metabolites in the uterus: in the nuclear fraction, there is a metabolite that is slightly less polar than cis-hydroxytamoxifen, and in the cytosol, a metabolite slightly more polar than cis-tamoxifen (but different from the nuclear metabolite). There is no evidence for isomerization of the isomers of tamoxifen or hydroxytamoxifen. In in vitro incubations with rat liver microsomes, both [3H]-trans-tamoxifen and [3H]-cis-tamoxifen undergo hydroxylation and to a lesser extent demethylation. Thus, the selective accumulation of trans-hydroxytamoxifen in the uterus appears to result from its greater affinity tor the estrogen receptor (285%, vs estradiol = 100%) relative to that of cis-hydroxytamoxifen (5%). The different metabolites that accumulate in the uterus following treatment with trans or cis tamoxifen may account for their different agonist-antagonist character.
UR - http://www.scopus.com/inward/record.url?scp=0020033521&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020033521&partnerID=8YFLogxK
U2 - 10.1016/0022-4731(82)90137-6
DO - 10.1016/0022-4731(82)90137-6
M3 - Article
C2 - 7062732
AN - SCOPUS:0020033521
SN - 0022-4731
VL - 16
SP - 1
EP - 13
JO - Journal of Steroid Biochemistry
JF - Journal of Steroid Biochemistry
IS - 1
ER -